BioFi's Revolutionary Phēnix X Blockchain Phone Achieves 4G Type Approval and Certification, Paving the Way for Nigerian Launch
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a trailblazing fintech company specializing in mobile technology and biometric authentication solutions, proudly announces that its revolutionary Phēnix X Blockchain phone has successfully attained the coveted 4G Type Approval certification in Nigeria. This significant milestone ensures seamless compatibility with mobile networks across Nigeria and paves the way for launches in other markets across Africa, Southeast Asia, and South America. The BioFi team is thrilled by this achievement as it prepares for the impending launch in the Nigerian market, on the heels of the Nigerian Communications Commissions (NCC) Approvals.
The Phēnix X is poised to revolutionize user experiences in Nigeria and other markets, offering advanced security, deep blockchain integration, immersive training capabilities, integrated partner content, and cutting-edge technological advancements. As a leading advocate and pioneer in mobile Blockchain technology, BioFi is committed to bringing its groundbreaking innovations to global markets, strategically partnering with key industry players to expedite the commercialization of decentralized products and services.
Brian Maw, CEO of Finnovant, expressed his enthusiasm regarding this pivotal development. "This marks an incredible milestone in the evolution of mobile Blockchain technology for BioFi," stated Maw. "Our meticulous focus on technology and innovation has laid the groundwork for the Phēnix X rollout in Nigeria and beyond. The Phēnix X's exceptional performance throughout the rigorous Type Approval process, without requiring any rework or redesign, is truly remarkable. BitMobile, our South African-based company driving the Phēnix X launch efforts in Nigeria, eagerly anticipates ongoing collaboration with our outstanding partners to deliver world-class security and advanced technology across the African continent."
The attainment of Type Approval certification is a crucial step towards the commercial launch of the Phēnix X in Nigeria, validating compliance with essential market requirements related to wireless capabilities, electromagnetic compatibility, and health and safety standards. The Phēnix X boasts robust 4G connectivity with backward compatibility to 3G and 2G, ensuring widespread support for carrier signals across the continent.
As the Phēnix X gains prominence, its impact is expected to extend beyond individual users. The device's focus on self-sovereign identity aligns with broader initiatives across the African continent aimed at empowering communities, fostering trust, and driving economic development. The convergence of decentralized education and self-sovereign identity on the Phēnix X represents a significant leap forward for Africa. The Phēnix X is not merely a communication tools; It is a catalyst for financial inclusion, digital literacy, and individual empowerment. As the Phēnix X becomes more prevalent across the continent, the potential to reshape the narrative of African innovation and progress becomes ever more apparent. The future is not just digital-it's decentralized and in the palm of your hand.
BioFi remains committed to future-proofing the Phēnix X by actively developing 5G mobile technology, aligning with the evolving connectivity landscape in Africa and globally. Stay tuned for the dawn of a revolutionary era in connectivity!
To stay updated on the future of Phēnix X and to order a device online as soon as they are available, connect on Finnovant's South African company website, BitMobile, at https://www.bitmobiletech.com/.
About Finnovant:
Finnovant Inc. was founded with the vision of helping business leaders dramatically improve their interactions with critical information and customers. Specializing in secure blockchain solutions across Financial Services, Governance, IoT, Healthcare, and more, Finnovant is dedicated to enhancing digital security through biometric authentication, countering Identity Theft and Fraud.
Follow Finnovant at Finnovant.com, X, LinkedIn, Facebook, Instagram, Telegram, Discord
About BitMobileTech:
BitMobileTech empowers individuals through blockchain solutions, fostering learning, growth, and prosperity. Our commitment to the global blockchain revolution and emerging technologies in Africa is unwavering. The Phēnix X devices will transform communication into catalysts for financial inclusion, digital literacy, and individual empowerment, helping reshape the narrative of African innovation. The future is decentralized.
Follow BitMobile at BitMobileTech.com.
Media Contact:
Chris Benedict
Finnovant, Inc.
1-888-426-1892
cbenedict@finnovant.com
SOURCE: Finnovant, Inc.
View the original press release on ACCESS Newswire
Finnovant Inc
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru16.7.2025 13:00:00 EEST | Press release
Appoints New CFO for the Copper Development Stage in Chile and Peru VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper trench results from the Mirador prospect located in the Diva trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. The new mineralized body identified at Mirador could represent the northwesterly continuation of the Adriana mineralized copper zone where over 20,000 meters of drilling has been completed. There are clear lithological, mineralogical, and structural similarities observed at Adriana, Mirador, and Katty that share the same structural control across the Diva trend fault. Importantly, this primary and oxide copper surface exposure mineralization is within intrusive, potential source rocks, that typically underlay the volcanic Chocolate Formation. The package of vol
Formerra to Supply Foster Medical Compounds Across the Americas15.7.2025 17:45:00 EEST | Press release
Following GEON's acquisition of Foster, LLC, this new agreement expands Formerra's healthcare polymer portfolio with life-saving medical compounds. ROMEOVILLE, IL / ACCESS Newswire / July 15, 2025 / Formerra, a leader in performance materials distribution, today announced an agreement with GEON® Performance Solutions that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in North America and South America. The agreement follows GEON's acquisition of Foster, LLC, and builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "This expanded partnership equips our customers with a broader set of proven medical-grade solutions while leveraging Formerra's technical guidance and robust supply-chain capabilities," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Foster's brand strength and GEON's investment momentum create powerful growth potential for these materials and our cust
FairWinds Migrates from .COM to .FAIRWINDS, Showcasing Leadership in Strategic Internet Addressing15.7.2025 17:00:00 EEST | Press release
WASHINGTON, DC / ACCESS Newswire / July 15, 2025 / FairWinds Partners, the world's leading domain name strategy consultancy, has completed the migration of its website from fairwindspartners.com to home.fairwinds. "This transition is more than a domain change. It reflects our belief in the future of .BRAND top-level domains," said FairWinds founder Josh Bourne. "Our move to .FAIRWINDS reinforces the strategic value that these top-level domains offer and our evolution from a pioneering domain name advisory firm to the trusted partner for global brands navigating the digital landscape via the address bar." Unlike second-level domains like google.com, top-level domains reside on the internet's root servers -- the foundation of the internet's naming system. .BRAND top-level domains are not publicly available and are used exclusively by the brand owner. ".BRAND top-level domains provide a powerful way to amplify, control, and secure a brand's digital presence while giving visitors visual pr
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup15.7.2025 14:00:00 EEST | Press release
Official Apparel and Team Sponsor Delivers a Commemorative Gift Collection Honoring the Global Sport Brand's 135th Anniversary Celebration WEST PALM BEACH, FLA. AND WINDSOR, U.K. / ACCESS Newswire / July 15, 2025 / U.S. Polo Assn., the official brand of the United States Polo Association (USPA), in partnership with Brand Machine Group (BMG), its licensing partner in the United Kingdom, proudly served once again as the Official Apparel and Team Sponsor for the 2025 Outsourcing Inc. Royal Charity Polo Cup. The prestigious event took place on July 11 at the renowned Windsor Great Park at Flemish Farms' Guards Polo Club.U.S. Polo Assn. (left to right) U.S. Polo Assn. Team Accepts Royal Charity Polo Cup Trophy: James Beim, HRH The Prince of Wales, J. Michael Prince (USPA Global), Boo Jalil (BMG), Aiyawatt Srivaddhanaprahba, and Amr Zeden In its seventh consecutive year of sponsorship for the charitable event, U.S. Polo Assn. outfitted all participating polo players, umpires, and flaggers in
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease15.7.2025 10:50:00 EEST | Press release
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB).AATec Medical and Northway Biotech Announce Partnership Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom